Skip to main content
. 2021 Nov 6;10(22):e021094. doi: 10.1161/JAHA.121.021094

Figure 3. Treatment effect of vericiguat compared with placebo on the primary composite end point (first heart failure hospitalization or cardiovascular death) according to baseline systolic blood pressure.

Figure 3